Stock & Company Details
Artelo Biosciences Inc $ARTL
Price:
N/A
N/A
548K
$1.3M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.06
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Retail Trade
ARTL technical indicators
Latest Artelo Biosciences Inc (ARTL) indicator readings as of 2026-10-29.
ARTL's 14-day RSI is 36.2, in neutral territory. At $2.31 it is trading 14.1% below its 200-day moving average of $2.69, and below its 50-day average of $3.60. Price sits in the middle of its Bollinger Bands ($1.95 to $3.76). ADX reads 42.4, indicating a trending market.
Overview
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network in body. It is focused on discovering, licensing, developing and commercializing treatments that control endocannabinoid system. The company pursues technologies and programs that offer proprietary approaches to cannabinoid-based therapies, also those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.
Finance Bot
Ask your questions
Start by typing a question below.
